CHI3L1 and myeloid sarcoma: We can’t make any determination of causality from our study, although the indirect evidence for pathogenicity of CHI3L1 does exist in the literature: subjects with clinically isolated syndrome (CIS) who had high CSF levels of CHI3L1 had greater and faster transition to clinically definite MS and a four-fold increased risk for the development of neurological disability compared to CIS subjects with low CSF CHI3L1 levels (Comabella et al., 2010; Canto et al., 2015).